ADXN
Price
$7.79
Change
-$0.01 (-0.13%)
Updated
Dec 18, 01:11 PM (EDT)
IGXT
Price
$0.17
Change
-$0.00 (-0.00%)
Updated
May 16 closing price
Ad is loading...

ADXN vs IGXT

Header iconADXN vs IGXT Comparison
Open Charts ADXN vs IGXTBanner chart's image
Addex Therapeutics
Price$7.79
Change-$0.01 (-0.13%)
Volume$100
CapitalizationN/A
IntelGenx Technologies
Price$0.17
Change-$0.00 (-0.00%)
Volume$37.23K
CapitalizationN/A
ADXN vs IGXT Comparison Chart
Loading...
View a ticker or compare two or three
VS
ADXN vs. IGXT commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADXN is a Buy and IGXT is a Sell.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (ADXN: $7.80 vs. IGXT: $0.17)
Brand notoriety: ADXN and IGXT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ADXN: 7% vs. IGXT: 100%
Market capitalization -- ADXN: $8.05M vs. IGXT: $29.17M
ADXN [@Biotechnology] is valued at $8.05M. IGXT’s [@Biotechnology] market capitalization is $29.17M. The market cap for tickers in the [@Biotechnology] industry ranges from $482.14B to $0. The average market capitalization across the [@Biotechnology] industry is $2.68B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADXN’s FA Score shows that 1 FA rating(s) are green whileIGXT’s FA Score has 1 green FA rating(s).

  • ADXN’s FA Score: 1 green, 4 red.
  • IGXT’s FA Score: 1 green, 4 red.
According to our system of comparison, both ADXN and IGXT are a bad buy in the long-term.

Price Growth

ADXN (@Biotechnology) experienced а -2.50% price change this week, while IGXT (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.67%. For the same industry, the average monthly price growth was -1.91%, and the average quarterly price growth was -1.42%.

Reported Earning Dates

ADXN is expected to report earnings on Apr 30, 2024.

IGXT is expected to report earnings on Nov 29, 2024.

Industries' Descriptions

@Biotechnology (-6.67% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

FUNDAMENTALS
Fundamentals
IGXT($29.2M) has a higher market cap than ADXN($8.78M). ADXN YTD gains are higher at: 28.926 vs. IGXT (20.905).
ADXNIGXTADXN / IGXT
Capitalization8.78M29.2M30%
EBITDAN/AN/A-
Gain YTD28.92620.905138%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
IGXT: Fundamental Ratings
IGXT
OUTLOOK RATING
1..100
47
VALUATION
overvalued / fair valued / undervalued
1..100
89
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
52
P/E GROWTH RATING
1..100
5
SEASONALITY SCORE
1..100
4

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME31.261.82
+6.18%
GameStop Corp
TSLA479.8616.84
+3.64%
Tesla
AAPL253.482.44
+0.97%
Apple
BTC.X106140.600000110.890625
+0.10%
Bitcoin cryptocurrency
SPY604.29-2.50
-0.41%
SPDR® S&P 500® ETF Trust

ADXN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ADXN has been loosely correlated with ANVS. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if ADXN jumps, then ANVS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADXN
1D Price
Change %
ADXN100%
-0.64%
ANVS - ADXN
34%
Loosely correlated
+2.20%
PHGUF - ADXN
25%
Poorly correlated
+10.58%
AGEN - ADXN
24%
Poorly correlated
+4.42%
KALV - ADXN
24%
Poorly correlated
-3.35%
CLDI - ADXN
22%
Poorly correlated
-1.14%
More

IGXT and

Correlation & Price change

A.I.dvisor tells us that IGXT and JAGX have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IGXT and JAGX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IGXT
1D Price
Change %
IGXT100%
N/A
JAGX - IGXT
22%
Poorly correlated
+2.62%
ADXN - IGXT
21%
Poorly correlated
-0.64%
KURA - IGXT
20%
Poorly correlated
-2.36%
CMVLF - IGXT
20%
Poorly correlated
N/A
GTBP - IGXT
14%
Poorly correlated
-0.80%
More